84 related articles for article (PubMed ID: 9519278)
1. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)-quinoxaline (NBQX) increases fibroblast growth factor mRNA levels after contusive spinal cord injury.
Follesa P; Wrathall JR; Mocchetti I
Brain Res; 1998 Jan; 782(1-2):306-9. PubMed ID: 9519278
[TBL] [Abstract][Full Text] [Related]
2. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma.
Wrathall JR; Teng YD; Marriott R
Exp Neurol; 1997 Jun; 145(2 Pt 1):565-73. PubMed ID: 9217092
[TBL] [Abstract][Full Text] [Related]
3. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline reduces glial loss and acute white matter pathology after experimental spinal cord contusion.
Rosenberg LJ; Teng YD; Wrathall JR
J Neurosci; 1999 Jan; 19(1):464-75. PubMed ID: 9870974
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cardiorespiratory parameters in rats after spinal cord trauma and treatment with NBQX, an antagonist of excitatory amino acid receptors.
Teng YD; Wrathall JR
Neurosci Lett; 1996 May; 209(1):5-8. PubMed ID: 8734896
[TBL] [Abstract][Full Text] [Related]
5. The role of kainic acid/AMPA and metabotropic glutamate receptors in the regulation of opioid mRNA expression and the onset of pain-related behavior following excitotoxic spinal cord injury.
Abraham KE; McGinty JF; Brewer KL
Neuroscience; 2001; 104(3):863-74. PubMed ID: 11440816
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonist NBQX.
Wrathall JR; Choiniere D; Teng YD
J Neurosci; 1994 Nov; 14(11 Pt 1):6598-607. PubMed ID: 7965063
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors.
Wrathall JR; Teng YD; Choiniere D
Exp Neurol; 1996 Jan; 137(1):119-26. PubMed ID: 8566203
[TBL] [Abstract][Full Text] [Related]
8. Evidence that local non-NMDA receptors contribute to functional deficits in contusive spinal cord injury.
Wrathall JR; Teng YD; Choiniere D; Mundt DJ
Brain Res; 1992 Jul; 586(1):140-3. PubMed ID: 1324778
[TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).
Swedberg MD; Jacobsen P; Honoré T
J Pharmacol Exp Ther; 1995 Sep; 274(3):1113-21. PubMed ID: 7562477
[TBL] [Abstract][Full Text] [Related]
10. White matter injury in spinal cord ischemia: protection by AMPA/kainate glutamate receptor antagonism.
Kanellopoulos GK; Xu XM; Hsu CY; Lu X; Sundt TM; Kouchoukos NT
Stroke; 2000 Aug; 31(8):1945-52. PubMed ID: 10926962
[TBL] [Abstract][Full Text] [Related]
11. Effect of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline on methamphetamine- and cocaine-induced behavioral sensitization.
Akiyama K; Ujike H; Sakai K; Shimizu Y; Kodama M; Kuroda S
Pharmacol Biochem Behav; 1998 Dec; 61(4):419-26. PubMed ID: 9802837
[TBL] [Abstract][Full Text] [Related]
12. Effects of the AMPA-receptor antagonist, NBQX, on neuron loss in dentate hilus of the hippocampal formation after 8, 10, or 12 min of cerebral ischemia in the rat.
Hu P; Diemer NH; Bruhn T; Johansen FF
J Cereb Blood Flow Metab; 1997 Feb; 17(2):147-52. PubMed ID: 9040493
[TBL] [Abstract][Full Text] [Related]
13. Increased basic fibroblast growth factor expression following contusive spinal cord injury.
Mocchetti I; Rabin SJ; Colangelo AM; Whittemore SR; Wrathall JR
Exp Neurol; 1996 Sep; 141(1):154-64. PubMed ID: 8797678
[TBL] [Abstract][Full Text] [Related]
14. Some behavioral effects of CNQX AND NBQX, AMPA receptor antagonists.
Maj J; Rogóz Z; Skuza G; Jaros T
Pol J Pharmacol; 1995; 47(4):269-77. PubMed ID: 8616504
[TBL] [Abstract][Full Text] [Related]
15. NBQX, a selective antagonist of the AMPA receptor, affects neither field potentials nor long-term potentiation in vivo.
Sato K; Morimoto K; Yamada N; Kuroda S; Hayabara T
Brain Res; 1995 Jun; 683(2):279-82. PubMed ID: 7552367
[TBL] [Abstract][Full Text] [Related]
16. NBQX, a competitive non-NMDA receptor antagonist, reduces degeneration due to focal spinal cord ischemia.
von Euler M; Seiger A; Holmberg L; Sundström E
Exp Neurol; 1994 Sep; 129(1):163-8. PubMed ID: 7925838
[TBL] [Abstract][Full Text] [Related]
17. Expression of cyclooxygenase-2 mRNA after global ischemia is regulated by AMPA receptors and glucocorticoids.
Koistinaho J; Koponen S; Chan PH
Stroke; 1999 Sep; 30(9):1900-5; discussion 1905-6. PubMed ID: 10471443
[TBL] [Abstract][Full Text] [Related]
18. Altered glutamate receptor function during recovery of bladder detrusor-external urethral sphincter coordination in a rat model of spinal cord injury.
Pikov V; Wrathall JR
J Pharmacol Exp Ther; 2002 Feb; 300(2):421-7. PubMed ID: 11805200
[TBL] [Abstract][Full Text] [Related]
19. Traumatic brain damage prevented by the non-N-methyl-D-aspartate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo[f] quinoxaline.
Bernert H; Turski L
Proc Natl Acad Sci U S A; 1996 May; 93(11):5235-40. PubMed ID: 8643559
[TBL] [Abstract][Full Text] [Related]
20. Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats.
Xu XJ; Hao JX; Seiger A; Wiesenfeld-Hallin Z
J Pharmacol Exp Ther; 1993 Oct; 267(1):140-4. PubMed ID: 8229741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
